<DOC>
	<DOC>NCT00104598</DOC>
	<brief_summary>This is a randomized study of message framing in individuals beginning a smoking cessation program utilizing bupropion SR and brief counseling, videos, and pamphlets.</brief_summary>
	<brief_title>Framing Messages for Smoking Cessation With Bupropion - 6</brief_title>
	<detailed_description />
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Pregnant or nursing women, or women of childbearing potential who are not using an adequate method of contraception Psychiatric illnesses requiring psychotropic medications (i.e., psychosis, major depression, mania), or the presence of suicidality or homocidality Current use of nicotine replacement therapies (i.e., nicotine patch, gum, or lozenges, nasal spray, or inhaler), bupropion (Zyban, Wellbutrin), or marijuana or current participation in another smoking cessation treatment Presence of unstable medical conditions (i.e., cardiac, hepatic, renal disease, diabetes mellitus) that would make a trial of bupropion SR hazardous Have taken monoamine oxidase inhibitors or metoprolol succinate within the past six weeks History of anorexia nervosa or bulimia Previous hypersensitivity to bupropion History of alcohol or other drug dependence in the past one year History of seizure disorder of any etiology (i.e., brain tumor, traumatic brain injury, substanceinduced seizures, etc.) Any finding that in the view of the principal investigator would compromise the subject's ability to fulfill the protocol visit schedule and visit requirements or put the subject at risk Sharing home or work environment with current or past participant No couples or participants who see each other every day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2013</verification_date>
</DOC>